KRAS and thyroid nodule: The RAS genes family (NRAS, HRAS, and KRAS) mutations represent the majority (about 70%) of all mutated cases, especially in indeterminate cytology, and they can be seen in histologically benign and malignant thyroid nodules [9, 14].